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Abstract: 
 
Schizotypy offers a useful construct for investigating the etiology, development, and expression 
of schizophrenia-spectrum psychopathology, as well as the comorbid expression of mood and 
anxiety disorders across the schizophrenia spectrum. The present study examined the 
associations of positive, negative, and disorganized schizotypy with affective symptoms and 
experiences in a sample of MTurk workers and college students (n = 575). Participants 
completed the Multidimensional Schizotypy Scale (MSS) and measures of depression, 
anxiety, social phobia, hypomanic traits, and state affect. As expected, positive schizotypy was 
significantly associated with hypomanic traits, whereas negative schizotypy was associated with 
reduced positive affect and reduced hypomanic traits. Although prior research has emphasized 
the association of positive schizotypy with depression and anxiety, the current results 
demonstrate that disorganized schizotypy is more strongly associated with elevated negative 
affect (over-and-above positive schizotypy). As such, these findings highlight the importance of 
examining disorganization of affect, in addition to the cognitive-behavioral deficits traditionally 
associated with disorganized schizotypy. Finally, the MSS and MSS-Brief demonstrated closely 
comparable findings. The present results provide further support for the construct validity of the 
MSS and the three-factor model of schizotypy. 
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Article: 
 
1. Introduction 
 
1.1. Schizophrenia and schizotypy 
 
Schizophrenia is a severe mental illness characterized by psychosis, negative symptoms, 
disordered thought and behavior, and marked functional deficits (American Psychiatric 
Association, 2013). Current models suggest that schizophrenia is the most extreme manifestation 
of a spectrum of clinical and subclinical impairment referred to as schizotypy (Kwapil and 
Barrantes-Vidal, 2015, Lenzenweger, 2010, Meehl, 1990). Schizotypy offers a useful construct 
as it encompasses subclinical manifestations, the psychosis prodrome, and schizophrenia-
spectrum disorders. The construct also provides a framework for investigating the etiology, 
development, and expression of schizophrenia-spectrum psychopathology (Kwapil and 
Barrantes-Vidal, 2015) without many of the confounds associated with clinical disorders (e.g., 
medication effects; Lenzenweger, 2006). Schizotypy and schizophrenia are heterogeneous, and 
this heterogeneity can be captured in a multidimensional structure that includes positive, 
negative, and disorganized dimensions (Kwapil and Barrantes-Vidal, 2015, Mason and Claridge, 
2006, Vollema and van den Bosch, 1995). Additionally, this multidimensional structure has been 
shown to be consistent across cultures (Fonseca-Pedrero et al., 2017, Fonseca-Pedrero et al., 
2018). Positive schizotypy involves odd beliefs, unusual perceptual experiences, and 
suspiciousness. Negative schizotypy is characterized by diminished functioning such as affective 
flattening, anhedonia, avolition, anergia, and social withdrawal. Disorganized schizotypy is 
characterized by disturbances in thought, speech, and behavior. In addition to providing 
information about clinical manifestations of schizotypy, understanding the nature of this 
construct and its dimensions should enhance our identification of individuals at risk for 
developing schizophrenia-spectrum disorders. 
 
1.2. Schizotypy and affective experiences 
 
Disruptions in the experience of emotion have been commonly implicated across the 
schizophrenia spectrum (as discussed below). Researchers have assessed affective symptoms in 
schizotypy, including the presence of depressive and anxious symptoms, as well as hypomanic 
traits. Further, differences in trait neuroticism and state affect have been observed. Assessment of 
these symptoms and experiences dimensionally in schizotypy provides information about 
patterns in the etiology and development of psychosis. 
 
1.2.1. Depression and anxiety 
 
Depressive and anxious symptoms are commonly present in patients with schizophrenia 
(American Psychiatric Association 2013, Sands and Harrow, 1999). Specifically, evidence 
suggests higher lifetime prevalence of depressive (Häfner et al., 2005) and anxious (Cosoff and 
Hafner, 1998) symptoms and episodes in patients with schizophrenia-spectrum disorders than in 
the general population. Although depressive symptoms share several characteristics with 
negative symptoms of schizophrenia (e.g., anhedonia, diminished motivation), research suggests 
that these affective symptoms are more strongly associated with positive, or psychotic-like, 
symptoms than with negative symptoms (Drake et al., 2004, Emsley et al., 1999, Lysaker et al., 
1995). 
 
Multidimensional models of schizotypy show similar associations with affective and anxious 
symptoms as seen in schizophrenia. For example, Lenzenweger and Loranger (1989) found that 
positive schizotypy was associated with higher levels of anxiety and depression. Lewandowski 
et al. (2006) further demonstrated that symptoms of depression and anxiety are more strongly 
associated with positive schizotypy than with negative schizotypy. Other researchers have 
indicated that individuals with both depressive and schizotypal features tend to demonstrate 
higher levels of paranoid and suspicious symptoms (Spitznagel and Suhr, 2004), which are 
conceptualized as core components of positive schizotypy. Likewise, social anxiety (Brown 
et al., 2008) and obsessive-compulsive symptoms (Einstein and Menzies, 2004, Norman et al., 
1996, Sobin et al., 2000) are more strongly associated with positive schizotypy than with 
negative schizotypy. This is consistent with the conceptualization that negative schizotypy is 
characterized by diminished affective expression and processing (Kerns, 2006), and is likely 
associated with reduced vulnerability to the high negative affect that is typically associated with 
depression and anxiety. 
 
1.2.2. Mania and hypomania 
 
In addition to the co-occurrence of depression and anxiety with positive schizotypy, evidence 
supports associations of manic and hypomanic symptoms with positive schizotypy. For example, 
approximately 50% of patients with bipolar I disorder experience psychotic symptoms during 
their lifetime (Goodwin and Jamison, 2007). Furthermore, schizophrenia and bipolar disorder 
tend to co-occur within families (Cardno and Owen, 2014). Positive, but not negative, schizotypy 
appears to be associated with risk for bipolar disorder and with hypomanic personality traits. 
Kwapil et al. (2013) reported that positive, but not negative, schizotypy predicted the 
development of manic or hypomanic episodes in the Chapmans’ ten-year longitudinal sample. In 
the derivation study of the Hypomanic Personality Scale (HPS), Eckblad and Chapman (1986) 
reported that scores on the HPS were significantly associated with positive schizotypy measures 
of magical ideation (r = 0.49) and perceptual aberrations (r = 0.43), but were inversely correlated 
with a negative schizotypy measure of physical anhedonia (r = −0.18). Unpublished data from 
1,594 college students assessed by our laboratory replicated these findings; scores on the HPS 
correlated 0.46 with positive schizotypy and −0.10 with negative schizotypy (Kwapil and 
Kemp, 2018). 
 
1.2.3. Neuroticism 
 
Models of personality traits, such as the Five-Factor Model, capture trait-like levels of emotional 
instability, depression, and anxiety in the personality dimension of neuroticism (McCrae and 
Costa, 2010). Neuroticism is elevated in patients with schizophrenia (Horan et al., 2008). Traits 
such as neuroticism have the potential to interact with schizotypy and may provide information 
about the relationship between affective and schizophrenic symptoms. For example, Meehl 
(1990) suggested that personality vulnerabilities such as neuroticism may increase the likelihood 
of people with schizotypy decompensating into full-blown psychosis. Much like the established 
relationship among mood, anxiety, and positive schizotypy, studies have reported that positive, 
but not negative, schizotypy is strongly associated with neuroticism (Barrantes-Vidal et al., 2009, 
Gross et al., 2014, Gross et al., 2018a, Kwapil et al., 2008, Kwapil et al., 2018a). Furthermore, 
neuroticism moderates the expression of schizotypy and may increase the likelihood of 
schizotypic individuals experiencing psychotic-like symptoms and transitioning into 
schizophrenia-spectrum disorders (Claridge and Davis, 2003). For example, Barrantes-Vidal et 
al. (2009) reported that neuroticism moderated the expression of positive, but not negative, 
schizotypy in the prediction of interview ratings of psychotic-like and schizotypal symptoms, as 
well as impaired functioning. 
 
1.2.4. State affect 
 
In addition to examining trait-like affective experiences in schizotypy, studies have also assessed 
schizotypy in relation to state positive affect (PA) and negative affect (NA). For example, 
schizotypy is generally associated with lower levels of PA (Watson and Naragon-Gainey, 2010) 
and higher levels of NA than healthy controls (Miller and Lenzenweger, 2014). PA and NA have 
also been assessed in daily life studies of schizotypy using experience sampling methodology 
(ESM). These studies have shown that the schizotypy dimensions are differentiated by their 
experience of affect in daily life. Specifically, positive schizotypy is associated with increased 
NA, whereas negative schizotypy is primarily associated with decreased PA (Barrantes-Vidal 
et al., 2013, Kwapil et al., 2012). This is consistent with the relationship of mood and anxiety 
symptoms with schizotypy discussed above. 
 
Studies examining the association of affective symptoms and experiences with schizotypy have 
primarily focused on positive and negative schizotypy dimensions, but not disorganized 
schizotypy. Furthermore, studies that have examined disorganized schizotypy have often relied 
on measures that tap other constructs such as eccentricity or social anxiety. Disorganized 
schizotypy is presumed to involve disruptions in the ability to organize and regulate thoughts, 
affect, and behavior and is strongly associated with both neuroticism and positive schizotypy 
(e.g., Kwapil et al., 2018). Therefore, it is essential to clarify the relationship of disorganized 
schizotypy and affective experiences. 
 
1.3. Psychometric assessment of schizotypy 
 
Questionnaire measures have been widely used for assessing schizotypic characteristics and 
examining risk for developing schizophrenia-spectrum psychopathology (see reviews by 
Chapman et al., 1995, Kwapil and Chun, 2015, Mason, 2015, Mason et al., 1997). Widely used 
measures of schizotypy include the Wisconsin Schizotypy Scales (WSS), which consists of the 
Perceptual Aberration (Chapman et al., 1978), Magical Ideation (Eckblad and Chapman, 1983), 
Physical Anhedonia (Chapman et al., 1976), and Revised Social Anhedonia (Eckblad et al., 
1982) Scales, the Schizotypal Personality Questionnaire (SPQ; Raine, 1991), and the Oxford-
Liverpool Inventory of Feelings and Experiences (O-LIFE; Mason et al., 1995). Brief versions 
have also been derived for each of these measures including the WSS-B (Winterstein et al., 
2011), SPQ-B (Raine and Benishay, 1995), and the O-LIFE-SV (Mason et al., 2005). Although 
these questionnaire measures of schizotypy have been widely employed, they suffer from a 
number of limitations including factor structures that are inconsistent with current conceptual 
models, outdated or biased items, and psychometric limitations. 
 
The Multidimensional Schizotypy Scale (MSS; Kwapil et al., 2018b) and the Multidimensional 
Schizotypy Scale-Brief (MSS-B; Gross et al., 2018b) were developed to assess current 
conceptualizations of positive, negative, and disorganized schizotypy and to address the 
limitations associated with existing measures of schizotypy. Scale construction followed the 
recommendations of DeVellis (2012). Classical test theory, item response theory, and differential 
item functioning were employed to derive the 77-item MSS and the 38-item MSS-B. Both 
measures contain positive, negative, and disorganized schizotypy subscales. The MSS and MSS-
B have good psychometric properties, good item discrimination, and minimal item bias for 
gender and race/ethnicity in large derivation (n = 6,265) and cross-validation (n = 1,000) 
samples. Coefficient alpha reliabilities range from 0.88 to 0.94 for the MSS subscales (Kwapil 
et al., 2018b) and 0.78 to 0.90 for the MSS-B subscales (Gross et al., 2018b), and both the MSS 
and MSS-B subscales demonstrate good to excellent test-retest reliability (Kemp et al., 2018). 
Furthermore, initial studies support the construct validity of the schizotypy subscales (e.g., Gross 
et al., 2018a, Kwapil et al., 2018a) and indicate comparable findings for the full-length and brief 
versions of the scale. However, studies have not examined the association of the MSS and MSS-
B schizotypy dimensions with measures of affective experiences. 
 
1.4. Goals and hypotheses 
 
The present study assessed the associations of positive, negative, and disorganized schizotypy 
with affective experiences including symptoms of depression, anxiety, social anxiety, hypomanic 
personality traits, and state positive and negative affect. To our knowledge, this is the first study 
to examine these associations using the MSS and the MSS-B positive, negative, and disorganized 
schizotypy subscales. We expected that the affective patterns in positive schizotypy and negative 
schizotypy would be comparable to those demonstrated in previous studies. Thus, we 
hypothesized that positive schizotypy would be strongly related to negative affect and symptoms 
of depression and anxiety, as well as hypomanic traits. Furthermore, we hypothesized that 
negative schizotypy would have a minimal relationship with negative affect and symptoms of 
depression and anxiety, and would be inversely associated with hypomanic traits and positive 
affect. Although the relationship between disorganized schizotypy and affective experiences has 
not been widely examined, we expected that disorganized schizotypy would be moderately 
associated with measures of negative affect, depression, and anxiety due to the established 
relationship of disorganized schizotypy with neuroticism and positive schizotypy. Finally, we 
expected that the associations of the schizotypy dimensions and affective experiences would be 
closely comparable for the MSS and MSS-B. Specifically, we expected that the magnitude of the 
associations would not diminish when using the MSS-B relative to the MSS, as evidenced by the 
fact that the effect sizes for the correlations and regression coefficients from analogous analyses 
would be of the same magnitude for the MSS and MSS-B. Such findings would provide further 
support for the use of the MSS-B as an abbreviated form of the MSS. 
 
2. Methods 
 
2.1. Participants 
 
Participants were recruited from two sources and completed online surveys via Qualtrics 
software. A total of 359 participants were recruited from across the United States through 
Amazon Mechanical Turk (MTurk) and 334 participants were recruited from the University of 
Illinois at Urbana-Champaign's Psychology Department participant pool. All participants were at 
least 18 years of age. Participants were dropped for invalid responding or for completing the 
survey in less than 10 minutes. Usable data were retained for 293 MTurk participants 
(M age = 38 years, SD = 11.3; 57% female; 8% Black, 4% Asian/Pacific Islander, 81% 
Caucasian, 5% Hispanic/Latino, < 1% Native American, 1% other; 98% Native English 
speakers) and 282 university participants (M age = 19.3 years, SD = 1.3; 62% female; 6% Black, 
21% Asian/Pacific Islander, 51% Caucasian, 17% Hispanic/Latino, < 1% Native American, 5% 
other; 83% Native English speakers). The total sample included 575 participants (M age = 28.8 
years, SD = 12.4; 60% female; 7% Black, 12% Asian/Pacific Islander, 67% Caucasian, 11% 
Hispanic/Latino, < 1% Native American, 3% other; 91% Native English speakers). Information 
was not obtained regarding psychiatric diagnoses or treatment. 
 
2.2. Measures 
 
2.2.1. Multidimensional schizotypy scale 
 
The MSS contains 77 true-false items and the MSS-B contains 38 items that assess positive, 
negative, and disorganized schizotypy. The items are presented in Kwapil et al. (2018b) and 
Gross et al. (2018b). Note that scores on the MSS-B were derived from the full-length MSS. 
Following recommendations of Kwapil et al. (2018b), separate scores were computed for each 
schizotypy dimension, as opposed to computing a total schizotypy score. 
 
2.2.2. Measures of affect and affective symptoms 
 
The 21-item Beck Depression Inventory-II (BDI; Beck et al., 1996) and the 21-item Beck 
Anxiety Inventory (BAI; Beck and Steer, 1993) assess the severity of recent depressive and 
anxiety symptoms, respectively. Note that one item assessing suicidal ideation was removed 
from the BDI at the request of the IRB. Items on the BDI and BAI share the same response 
format with responses ranging from 0 (no symptom endorsement) to 3 (severe symptom 
endorsement). The BDI has high coefficient-alpha reliability for patients with clinical depression 
(0.92), as well as nonclinical individuals (0.93; Beck et al., 1996). The BAI has similarly high 
internal consistency (0.92; Beck et al., 1988). 
 
The Social Phobia Scale (SPS) assesses the severity of social anxiety symptoms. It has good 
coefficient alpha reliability (0.89; Mattick and Clarke, 1998). Responses are on a Likert 
scale ranging from 1 (“strongly disagree”) to 7 (“strongly agree”). The Positive and Negative 
Affect Schedule (PANAS; Watson et al., 1988) contains 20 words that describe positive or 
negative emotions (e.g., “Excited”). Participants are instructed to indicate the extent to which 
they experienced the emotion within the last week on a scale of 1 (very slightly or not at all) to 5 
(extremely). The PANAS has demonstrated high coefficient-alpha reliabilities in its assessment 
of both positive (0.88) and negative affect (0.87). 
 
The Hypomanic Personality Scale (HPS; Eckblad and Chapman, 1986) is a self-report 
questionnaire that contains 48 true-false items that assess hypomanic personality traits. The HPS 
has good coefficient-alpha reliability (0.87) and test-retest reliability (0.81). High scorers on the 
scale are at elevated risk for hypomanic and manic episodes (Kwapil et al., 2000, Walsh et al., 
2015). 
 
2.2.3. Infrequency questionnaire 
 
A 13-item infrequency questionnaire (Chapman and Chapman, 1983) was included to screen out 
invalid responders. Following Chapman and Chapman, participants who endorsed more than two 
infrequency items were excluded from the analyses. 
 
2.3. Procedures 
 
Participants were recruited through MTurk and the university subject pool. All participants 
completed the questionnaires using the Qualtrics online survey system. The project received IRB 
approval from the University of Illinois at Urbana-Champaign and participants provided 
informed consent prior to completing the surveys. The survey began with demographic questions 
(age, sex, race/ethnicity, and English as first language). The MSS, HPS, and the infrequency 
questionnaire items (all true-false response) were intermixed and divided into five blocks. These 
five blocks were presented in random order after the demographic questionnaires. The remaining 
questionnaires (BDI, BAI, SPS, and PANAS) were then administered in random order. MTurk 
participants received $1 for completing the survey and university participants received course 
credit. 
 
3. Results 
 
3.1. Descriptive statistics 
 
Descriptive statistics for the questionnaires are presented in Table 1. Note that descriptive 
statistics and coefficient alpha reliabilities from the MSS and MSS-B are comparable to results 
from previous samples. Likewise, the intercorrelations of the MSS and MSS-B subscales 
(presented in Table 2) are comparable to previous findings (Gross et al., 2018a; Kwapil et al., 
2018a, b). In general, each measure exhibited good to excellent internal consistency reliability. A 
total of 37 participants failed to complete 1 questionnaire item (out of 219 possible items), and 8 
participants failed to complete 2 items. The remaining 530 participants completed all of the 
items. 
 
Table 1. Descriptive statistics for the schizotypy and affective measures. 
Criterion Mean S.D. Range Coefficient Alpha Skew Standard Error Kurtosis Standard Error 
Multidimensional Schizotypy Scale 
       
 Positive Schizotypy 2.53 3.46 0–26 .85 2.26 0.10 6.64 0.20 
 Negative Schizotypy 3.83 4.66 0–26 .89 1.88 0.10 3.89 0.20 
 Disorganized Schizotypy 3.61 5.28 0–25 .93 1.80 0.10 2.72 0.20 
Multidimensional Schizotypy Scale-Brief 
      
 Positive Schizotypy 1.30 1.80 0–13 .71 2.13 0.10 6.11 0.20 
 Negative Schizotypy 1.73 2.38 0–13 .80 1.98 0.10 4.10 0.20 
 Disorganized Schizotypy 1.56 2.61 0–12 .88 2.01 0.10 3.46 0.20 
Beck Depression Inventory 10.71 11.03 0–54 .94 1.24 0.10 1.04 0.20 
Beck Anxiety Inventory 10.01 10.38 0–56 .94 1.45 0.10 1.97 0.20 
Social Phobia Scale 61.74 25.83 19–130 .95 0.35 0.10 −0.69 0.20 
Hypomanic Personality Scale 14.24 8.39 0–41 .89 0.61 0.10 −0.13 0.20 
PANAS Positive Affect 30.05 8.28 10–50 .91 −0.05 0.10 −0.50 0.20 
PANAS Negative Affect 19.37 8.19 10–46 .91 0.88 0.10 0.11 0.20 
Note: PANAS = Positive and Negative Affect Schedule. 
 
3.2. Association of MSS/MSS-B and affective experiences 
 
Table 2 presents the zero-order correlations of the MSS and MSS-B subscales and the measures 
of affective experiences (depressive and anxious symptoms, hypomanic personality, state PA and 
NA). Given the large sample size and number of analyses for this study, alpha was set to 0.001 in 
order to minimize Type I error and avoid interpreting miniscule effects as statistically significant. 
Effect sizes are noted in the tables following Cohen (1992). The correlations were closely 
comparable for the analogous MSS and MSS-B subscales. The measures of affective experiences 
tended to have their strongest association with disorganized schizotypy at the level of a medium 
or large effect. 
 
Table 2. Correlations of the schizotypy and affective measures (n = 575).  
PosSz NegSz DisSz BDI BAI SPS HPS PA NA 
Multidimensional Schizotypy Scale; Multidimensional Schizotypy Scale-Brief 
   
 Positive Schizotypy (PosSz) 
 
.17*/.16* .38*/.34* .22*/.17* .23*/.20* .20*/.18* .47*/.45* .01/.04 .22*/.16* 
 Negative Schizotypy (NegSz) 
  
.34*/.36* .36*/.33* .16*/.14 .29*/.26* −.06/−.11 −.39*/−.36* .16*/.15* 
 Disorganized Schizotypy (DisSz) 
   
.59*/.55* .46*/.44* .43*/.42* .37*/.34* −.33*/−.32* .47*/.44* 
Beck Depression Inventory (BDI) 
    
.65* .46* .24* −.50* .68* 
Beck Anxiety Inventory (BAI) 
     
.44* .29* −.30* .71* 
Social Phobia Scale (SPS) 
      
.03 −.29* .41* 
Hypomanic Personality Scale (HPS) 
       
.16* .29* 
PANAS Positive Affect (PA) 
        
−.28* 
PANAS Negative Affect (NA) 
         
*p < .001. 
Note: Multidimensional Schizotypy Scale correlations on left, Multidimensional Schizotypy Scale-Brief correlations 
on right. Medium effect sizes in bold, large effect sizes in bold and italics. PANAS = Positive and Negative Affect 
Schedule. 
 
Table 3. Linear regressions examining prediction by the Multidimensional Schizotypy Scale 
factors (n = 575).  
MSS-Positive Schizotypy MSS-Negative Schizotypy MSS-Disorganized Schizotypy  
Criteria: β ΔR2 f2 β ΔR2 f2 β ΔR2 f2 Total R2            
BAI .063 .003 .004 −.006 .000 .000 .437* .147 .187 .214* 
BDI −.018 .000 .000 .181* .029 .046 .531* .218 .350 .373* 
SPS .038 .001 .001 .163* .023 .030 .358* .099 .125 .209* 
HPS .395* .133 .193 −.229* .046 .067 .298* .069 .100 .310* 
PANAS PA .181* .028 .036 −.315* .087 .112 −.294* .067 .085 .221* 
PANAS NA .049 .002 .003 −.001 .000 .000 .451* .157 .202 .222* 
*p < .001. 
Note: medium effect sizes (f2) in bold. BAI = Beck Anxiety Inventory; BDI = Beck Depression Inventory; 
SPS = Social Phobia Scale; HPS = Hypomanic Personality Scale; PANAS PA/NA = Positive and Negative Affect 
Schedule Positive Affect/Negative Affect. Each row represents a separate regression analysis in which the three 
MSS factors were entered simultaneously as predictors to examine their unique prediction of each affective measure 
score. 
 
In order to examine the unique associations of the MSS and MSS-B schizotypy subscales with 
affective symptoms and experiences, we regressed each of the affective measure scores on the 
three MSS and three MSS-B subscales (see Tables 3 and 4). Each row in the tables represents a 
separate regression analysis in which the three MSS or MSS-B subscales were entered 
simultaneously to examine their unique prediction of each of the affective experience scores. The 
standardized regression coefficient (β), change in R2, and effect size f2 are reported for each 
predictor in the linear regressions. Following Cohen (1992), f2 values above 0.15 are medium 
effect sizes, and above 0.35 are large effect sizes. Note that R2 and f2 were computed for each 
predictor by rerunning the analyses with the specific MSS predictor entered at the second step, 
over and above the other two MSS subscales. In order to examine the impact of multicollinearity, 
variance inflation factor (VIF) was computed for the three MSS and three MSS-B predictors, 
following Aiken et al. (2003). All VIF values were less than 1.3, indicating that multicollinearity 
did not adversely impact either set of regression analyses. 
 
Table 4. Linear regressions examining prediction by the Multidimensional Schizotypy Scale-
Brief factors (n = 575).  
MSS-Positive Schizotypy MSS-Negative Schizotypy MSS-Disorganized Schizotypy  
Criteria: β ΔR2 f2 β ΔR2 f2 β ΔR2 f2 Total R2            
BAI .061 .003 .004 −.020 .000 .000 .426* .144 .179 .197* 
BDI −.026 .001 .001 .155* .021 .031 .505* .202 .300 .326* 
SPS .042 .002 .002 .123 .013 .017 .357* .101 .124 .188* 
HPS .383* .130 .177 −.170* .025 .034 .271* .058 .079 .266* 
PANAS PA .179* .028 .035 −.292* .074 .092 −.273* .059 .074 .199* 
PANAS NA .017 .000 .001 −.008 .000 .000 .435* .150 .186 .193* 
*p < .001. 
Note: medium effect sizes (f2) in bold. BAI = Beck Anxiety Inventory; BDI = Beck Depression Inventory; 
SPS = Social Phobia Scale; HPS = Hypomanic Personality Scale; PANAS PA/NA = Positive and Negative Affect 
Schedule Positive Affect/Negative Affect. Each row represents a separate regression analysis in which the three 
MSS factors were entered simultaneously as predictors to examine their unique prediction of each affective measure 
score. 
 
The MSS and MSS-B positive schizotypy dimensions were significantly associated with 
hypomanic traits (medium effect size) and PA (small effect). The zero-order associations of 
positive schizotypy with measures of depressive and anxious symptoms and NA were better 
accounted for by disorganized than positive schizotypy in the regression analyses. Furthermore, 
the association of positive schizotypy with PANAS PA in the regression analysis (compared to 
the nonsignificant zero-order relation) appears to represent a suppression effect due to 
disorganized schizotypy, not negative schizotypy. Note that post hoc examination of the partial 
correlations of positive schizotypy and PA with disorganized schizotypy partialed out and 
negative schizotypy partialed out revealed that the suppression effect only occurred when 
partialing disorganized schizotypy. 
 
As expected, MSS and MSS-B negative schizotypy had significant inverse associations with 
hypomanic traits and PA. MSS negative schizotypy also had modest significant associations with 
depression and social anxiety, whereas MSS-B negative schizotypy was not associated with 
social anxiety. In order to better understand the association of negative schizotypy and BDI 
scores, we examined the correlation of the individual BDI items with the MSS negative 
schizotypy score. Not surprisingly, the strongest correlations were with the BDI items “loss of 
interest” (r = 0.45), “loss of pleasure” (r = 0.43), and “loss of interest in sex” (r = 0.35). Note that 
when positive and disorganized schizotypy were partialed out of this analysis, none of the NA 
items on the BDI remained significantly correlated with negative schizotypy. Thus, the 
association of negative schizotypy with the BDI appears largely driven by items tapping loss of 
pleasure and interest in the world, not items tapping increased NA (see Supplemental Table 1). 
 
MSS disorganized schizotypy demonstrated the strongest association with affective experiences, 
over-and-above the other schizotypy dimensions. Specifically, it was associated with depressive 
and anxious symptoms (medium effect), social phobia symptoms (small effect), hypomanic traits 
(small effect), increased NA (medium effect), and decreased PA (small effect). 
In order to examine whether the associations of the MSS and MSS-B positive, negative, and 
disorganized subscales with the measures of affective symptoms and experiences differed in the 
MTurk and college student sample groups, we computed the positive schizotypy x group, 
negative schizotypy x group, and disorganized schizotypy x group interactions for each of the 
outcome measures. None of the interactions for the MSS (Supplemental Table 2) or the MSS-B 
(Supplemental Table 3) was significant, indicating that the associations of schizotypy and affect 
were comparable in the MTurk and college student samples. 
 
Although we did not offer specific hypotheses regarding sex differences in these associations, we 
recomputed the regression analyses with sex as a moderator variable. However, none of the sex 
by schizotypy dimension score interactions significantly predicted any of the affect measures, 
indicating that the association of schizotypy dimensions with affect is invariant across sex (see 
Supplemental Tables 2 and 3). 
 
4. Discussion 
 
Evidence suggests that mood and anxiety symptoms often co-occur with schizophrenia-spectrum 
disorders (Cosoff and Hafner, 1998, Goodwin and Jamison, 2007, Häfner et al., 2005, Sands and 
Harrow, 1999) and this comorbidity can be observed across the continuum from 
subclinical schizotypy to clinically-identified schizophrenia (Brown et al., 2008, Eckblad and 
Chapman, 1986, Lenzenweger and Loranger, 1989, Lewandowski et al., 2006, Norman et al., 
1996, Spitznagel and Suhr, 2004). The presence of affective and anxiety symptoms has further 
implications for the presentation and course of schizophrenia-spectrum psychopathology. For 
example, positive symptoms in schizophrenia are often accompanied by mood and anxiety 
symptoms and are associated with better prognosis than negative symptoms in schizophrenia 
(Oosthuizen et al., 2002). Similarities in expression from schizotypy to schizophrenia suggest 
that studying affective symptoms in schizotypy can provide information about comorbidity in 
schizophrenia without the confounds of clinical populations. 
 
Previous research has assessed the relationship between schizotypy and affective experiences 
(e.g., Brown et al., 2008, Lewandowski et al., 2006), but these studies suffer from a number of 
limitations including outdated schizotypy measures and either exclusion of disorganized 
schizotypy or inclusion of problematic measures of disorganization. The present study is the first 
to examine the association of schizotypy with affective symptoms and experiences using the 
MSS and MSS-B. These measures offer the advantage of measuring positive, negative, and 
disorganized schizotypy based upon current conceptualizations of these dimensions. Although 
relatively new, the MSS and MSS-B have demonstrated good to excellent internal 
consistency, test-retest reliability, and initial construct validity. 
 
Our findings indicate several themes characterizing the relationship between the schizotypy 
dimensions and affective symptoms and experiences. First, disorganized schizotypy showed the 
strongest associations with affective and anxious symptoms and increased NA. Of note, 
however, hypomanic traits were strongly associated with positive schizotypy. This is consistent 
with current models that view positive symptoms and mania as overlapping constructs 
(Murray et al., 2004). The relationship between disorganized schizotypy and these experiences 
aligns with the conceptualization of disorganized schizotypy, as well as disorganized symptoms 
of schizophrenia. Specifically, disorganization is comprised of both cognitive and emotional 
dysregulation, though the former tends to be more typically emphasized (Bleuler, 1950, Kerns, 
2006). The experience of NA and related symptoms may be a direct response to cognitive 
dysregulation, and thus may be an important and overlooked aspect of disorganized schizotypy. 
 
Second, disorganized schizotypy was associated with all experiences characterized by elevated 
NA (i.e., measures of affective symptoms and PANAS NA) over-and-above positive schizotypy. 
Previous studies have suggested that positive schizotypy is strongly associated with depression 
and anxiety (e.g., Brown et al., 2008, Lewandowski et al., 2006); however, the present study 
suggests that those zero-order findings are better explained by disorganized schizotypy. Note 
again that the measures used in previous studies failed to capture disorganized schizotypy. 
Therefore, these prior findings may be due to the moderate zero-order correlation between 
positive and disorganized schizotypy. Given this correlation, the factor linking these two 
dimensions may be affective dysregulation. 
 
Thinking further about these relationships, it is important to consider how positive and 
disorganized schizotypy may be associated through features that perpetuate NA. Positive 
schizotypy is characterized by unusual thought content, odd perceptual experiences, 
and suspiciousness, which may produce NA and associated experiences (as well as being driven 
or exacerbated by NA). For example, suspiciousness of other people may result in increased 
symptoms of social anxiety and distress. On the other hand, disorganized schizotypy involves 
disruptions in the ability to organize and regulate thought and affect that often may be conflated 
with positive schizotypy. Kerns (2005) noted that positive schizotypy was associated with 
reduced clarity of emotions. However, this study only assessed the positive dimension of 
schizotypy; therefore, the findings may have been driven by the association between positive and 
disorganized schizotypy. Furthermore, deficits in clarity of emotion are associated with more 
cognitive difficulties under stress (Gohm et al., 2001). In this regard, affective dysregulation may 
link positive and disorganized schizotypy through cognitive difficulties in coping with stress, 
such as that generated from suspiciousness. 
 
Finally, negative schizotypy was strongly associated with reduced PA in the present study. This 
is in line with conceptualizations that anhedonia is a core component of negative schizotypy 
(e.g., Kwapil and Barrantes-Vidal, 2015). This finding is also consistent with previous work 
assessing state affect in daily life, which has indicated inverse relationships between negative 
schizotypy and state PA (e.g., Kwapil et al., 2012). Although negative schizotypy demonstrated a 
modest relationship with symptoms characterized by NA (i.e., depressive symptoms), follow-up 
analyses demonstrated that this association was relatively specific to items tapping anhedonic 
experiences of depression (i.e., reductions in PA) rather than NA itself. Thus, the relationship 
between negative schizotypy and depression may be best understood in terms of how negative 
schizotypy is traditionally conceptualized—as a diminution of affective expression and 
processing, including the experience of pleasure. 
 
Given that current conceptualizations of schizotypy include the three dimensions of positive, 
negative, and disorganized schizotypy, the current study supports the use of the MSS and MSS-B 
in evaluating the differential associations of these dimensions. The alignment of these 
associations with current conceptualizations of schizotypy traits and deficits serves to further 
validate the MSS and MSS-B subscales. Furthermore, the results did not considerably differ 
between the MSS and MSS-B in either the zero-order correlations or the regression analyses, and 
the magnitude of effect sizes was comparable for all of the analogous analyses for the two 
versions of the scale. The correspondence of the findings between the MSS and MSS-B provides 
additional support for the validity of the MSS-B as a short form of the original MSS and builds 
upon previous validation studies that found comparable findings for the scales (e.g., Gross et al., 
2018a, Kwapil et al., 2018a). 
 
Limitations of the current study include the use of retrospective self-report and a cross-sectional 
design. However, given the personal nature of items that are unlikely to be observed by others 
(e.g., Occasionally I have felt as though my body did not exist), self-report provides an effective 
method for capturing these experiences. Note that schizotypy studies often are limited to only 
using college student samples. The inclusion of the MTurk subsample, along with the college 
student subsample, provided a more diverse sample in which to examine schizotypic 
characteristics and their relations with affective experiences. The present study used a cross-
sectional design to assess schizotypy and affective experiences; therefore, we are unable to 
determine the direction of causality in the reported relationships. Nevertheless, establishing a 
pattern of associations at one time provides information about the manifestation of these 
symptoms on the schizotypy continuum. Future studies should examine the developmental nature 
of these relationships using longitudinal study designs to establish temporal precedence. 
 
In summary, this is the first study to our knowledge assessing relationships among the MSS and 
MSS-B subscales and affective experiences and symptoms. In contrast to prior research 
evaluating schizotypy and these affective experiences, the current study provides evidence that 
disorganized schizotypy may better explain the relationship between positive schizotypy and NA 
and its associated symptoms. Although disorganized schizotypy is traditionally conceptualized as 
a cognitive-behavioral deficit in the schizophrenia spectrum, our research suggests that 
disorganization of affect may be a central and overlooked aspect of disorganized schizotypy and 
schizophrenia. The MSS and MSS-B demonstrated sensitivity in detecting the distinct 
associations of the schizotypy dimensions and affective experiences without conflating positive 
and disorganized schizotypy. Thus, the present study also provides support for use of both the 
MSS and MSS-B as valid measures of the construct schizotypy. 
 
Supplementary materials. Supplementary material associated with this article can be found, in 
the online version, at doi:10.1016/j.psychres.2018.10.031. 
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